COVID Antibody Infusion Therapy

Most COVID-19 patients experience mild symptoms. But, some people are more likely to develop severe symptoms and get hospitalized. Such people require intensive care and treatment. The virus infection which causes COVID-19 destroys your immune system.

If you are at high risk for developing more severe COVID-19 symptoms, you are eligible for monoclonal antibody treatment.

What Are Monoclonal Antibodies?

Antibodies are part of our natural defense against viruses such as SARS-CoV-2, and COVID-19. But our bodies take time to make them. To fight against the COVID-causing virus artificial antibodies are created called “Monoclonal” antibodies. Monoclonal antibody infusion aims to boost your immune system. These monoclonal antibodies help reduce the risk of progressing severe symptoms of COVID-19.

As a result, the immune system plays a vital role in our life. Learn more about the immune system and how you can boost your immune system to fight against COVID-19.

Who is eligible for the Antibodies Infusion Therapy?

The FDA has granted Emergency Use Authorization (EUA) only for individuals who are at high risk for developing severe COVID-19. The monoclonal antibody treatments help keep patients out of hospitals and safe at home. Monoclonal antibody therapy needs to be given as soon as symptoms start to work. It should be given ideally within 4 days but, no longer than 7 days.

The eligible criteria of patients for Monoclonal Antibody infusion therapy are:

  • Mild or moderate symptoms of COVID-19 for no more than seven days

  • Age 65 years and older

  • Chronic health problem

  • Diabetes

  • Heart disease or respiratory disease

  • Chronic kidney disease

  • Obesity

  • Immunocompromised due to cancer diagnosis or transplant

  • Cardiovascular disease

  • Test positive for SARS-CoV-2

How does monoclonal antibody therapy work?

Monoclonal antibody infusion treatment is a new way of treating COVID-19 patients. These man-made antibodies are similar to our naturally made antibodies. However, monoclonal antibodies are mass with the spike protein on its outer shell produced in a laboratory, and it recognizes a specific component of this virus. By targeting the spike protein, these specific antibodies interfere with the virus' attachment and ability to gain entry into human cells.

These proteins essentially block the virus from getting into your body cells and start building your immune system. Patients can receive antibodies through IV infusion in our clinic. These treatments last around 2½ hours.

Use of Monoclonal Antibodies

To treat diseases monoclonal antibodies are used as immunotherapy. Because each type of monoclonal antibody will target a specific antigen in the body.

Monoclonal antibodies used to treat the below diseases:

  • Cancer

  • Rheumatoid arthritis

  • Multiple sclerosis

  • Cardiovascular disease

  • Systemic lupus erythematosus

  • Crohn's disease

  • Ulcerative colitis

  • Psoriasis

  • Transplant rejection

What are the side effects of monoclonal antibodies?

The monoclonal antibody may or may not cause any side effects. The side effects are dependent on the type of monoclonal antibody.

Common side effects are:

  • Allergic reactions

  • Chills

  • Weakness

  • Diarrhea

  • Nausea

  • Vomiting

  • Rash

  • Itching

  • High blood glucose levels

  • Cough

  • Constipation

  • Shortness of breath

  • Headache

  • Fever

  • Muscle aches and pain

  • Decreased appetite

  • Insomnia

  • Abdominal pain

  • Back pain

  • Dizziness

Other Available Treatments

If you have tested positive COVID and because of any reason you are not able to receive antibody treatment. Contact our Post-Covid Center to get information for other therapies. We have many other options for you.

To find out if you are at high risk and eligible for Monoclonal Antibody infusion therapy, please call us at +1 (469) 545-9983. We offer both telehealth and in-person appointments.

Post Covid Syndrome vs. Fatigue

While COVID-19 is a short-lived disease in most people, others experien...

Post Covid Syndrome vs. Skin Weakness Problems

A new study illustrates that some patients with COVID-19 disease have continuous skin-associated symptoms...